Skip to main content
Clinical Trials/IRCT2015022821269N1
IRCT2015022821269N1CompletedPhase 2

Pain relieving effect of intra-operative chemical splanchnicectomy of celiac ganglions in patients with resectable pancreatic or gastric masses: a randomized clinical trial

Vice chancellor for research, Iran University of Medical Sciences0 sites44 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Resectable pancreatic cancer or gastric cancer; Obtaining informed consent for probable alcohol injection during surgery.
  • Exclusion criteria: Unresectable pancreatic cancer; Unresectable gastric cancer; Patients those who underwent neo-adjuvant chemotherapy; Patients who dissatisfaction with the procedures; Patients who expires before 4 month after operation; Prolonged post-operation hospitalization (more than 15 days) due to surgical complications; Age less than 15 or more than 80 year; History of prolonged consumption of opioids, NSAIDS, analgesic and anti-depressant drugs; Cardiac or pulmonary diseases; Sensitivity to opioid drugs; Psychological disorders; Abnormal arterial blood gas analysis; Happening of surgical complications or any other signs that results in disability to complete pain scale questionnaire (such as loss of consciousness).

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Iran University of Medical Sciences

Similar Trials